Literature DB >> 19339135

Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking.

Peter Gariti1, Kevin Lynch, Arthur Alterman, Klye Kampman, Hu Xie, Kristi Varillo.   

Abstract

The study examined the impact of counseling intensity (high vs. low) combined with either bupropion or the nicotine patch. Two hundred sixty participants smoking 6 to 15 cigarettes per day (cpd) were enrolled in a year-long study to examine the effects of treatment. Four groups of smokers under medication-blinded conditions were compared for treatment completion and abstinence at three follow-up points from the initiation of treatment (Weeks 12, 26, and 52). Both counseling groups had similar treatment completion rates (i.e., defined by a combination of counseling attendance and medication adherence levels). There was a main treatment effect for abstinence favoring the high counseling condition in early follow-up (Week 12) and for continuous abstinence. Participants with a history of heavier smoking (> or =20 cpd) and African American smokers were least likely to be smoke free at the end of the study. The study has implications for identifying the treatment needs of lighter smokers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339135      PMCID: PMC2778325          DOI: 10.1016/j.jsat.2009.01.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  21 in total

1.  Comparison of smoking relapse curves among African-American smokers.

Authors:  Won S Choi; Kolawole S Okuyemi; Harsohena Kaur; Jasjit S Ahluwalia
Journal:  Addict Behav       Date:  2004-11       Impact factor: 3.913

2.  Predictors of quitting smoking: the NHANES I followup experience.

Authors:  W P McWhorter; G M Boyd; M E Mattson
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Why do those who request smoking treatment fail to attend the first appointment?

Authors:  Peter Gariti; Sarah Levin; Thomas Whittingham; Daniela Barou; Kyle M Kampman; Kevin Lynch; Chanita Hughes Halbert; Arthur Alterman
Journal:  J Subst Abuse Treat       Date:  2007-10-10

4.  Self-efficacy as a predictor of relapse following voluntary cessation of smoking.

Authors:  A J Yates; J Thain
Journal:  Addict Behav       Date:  1985       Impact factor: 3.913

5.  Reliability of alcohol abusers' self-reports of drinking behavior.

Authors:  L C Sobell; S A Maisto; M B Sobell; A M Cooper
Journal:  Behav Res Ther       Date:  1979

Review 6.  A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.

Authors: 
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

9.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03

10.  Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.

Authors:  John P Pierce; Elizabeth A Gilpin
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

View more
  22 in total

1.  Enhancing the effectiveness of smoking cessation interventions: a cancer prevention imperative.

Authors:  Anthony J Alberg; Matthew J Carpenter
Journal:  J Natl Cancer Inst       Date:  2012-01-25       Impact factor: 13.506

2.  Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.

Authors:  Lisa Sanderson Cox; Nicole L Nollen; Matthew S Mayo; Won S Choi; Babalola Faseru; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia
Journal:  J Natl Cancer Inst       Date:  2012-01-25       Impact factor: 13.506

3.  A pilot clinical trial of varenicline for smoking cessation in black smokers.

Authors:  Nicole L Nollen; Lisa Sanderson Cox; Niaman Nazir; Edward F Ellerbeck; Ashli Owen; Sydni Pankey; Nia Thompson; Jasjit S Ahluwalia
Journal:  Nicotine Tob Res       Date:  2011-04-15       Impact factor: 4.244

4.  Interventions to increase adherence to medications for tobacco dependence.

Authors:  Gareth J Hollands; Felix Naughton; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

5.  What Factors Influence Non-Adherence to the Smoking Cessation Program?

Authors:  Nagihan Durmuş Koçak; Ülkü Aka Aktürk
Journal:  Turk Thorac J       Date:  2019-04-01

Review 6.  Individual behavioural counselling for smoking cessation.

Authors:  Tim Lancaster; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

7.  CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.

Authors:  A Z X Zhu; L S Cox; N Nollen; B Faseru; K S Okuyemi; J S Ahluwalia; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2012-11-14       Impact factor: 6.875

8.  Cigarette Smoking Reduction in Pregnant Women With Opioid Use Disorder.

Authors:  Anita Ram; Michelle Tuten; Margaret S Chisolm
Journal:  J Addict Med       Date:  2016 Jan-Feb       Impact factor: 3.702

9.  Differences between intermittent and light daily smokers in a population of U.S. military recruits.

Authors:  Theodore V Cooper; Thom Taylor; Ashley Murray; Margaret W DeBon; Mark W Vander Weg; Robert C Klesges; G Wayne Talcott
Journal:  Nicotine Tob Res       Date:  2010-03-04       Impact factor: 4.244

10.  Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.

Authors:  Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox
Journal:  Addict Behav       Date:  2012-11-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.